Last Updated: April 16, 2026 · Medically Reviewed by Dr. Robert Sullivan, MD
Saw Palmetto is an extract from the berries of the Serenoa repens dwarf palm. It is the most-studied botanical worldwide for benign prostatic hyperplasia (BPH) and lower urinary tract symptoms in aging men. Its primary mechanism is inhibition of 5-alpha reductase — the enzyme that converts testosterone into DHT in prostate tissue.
Saw Palmetto (Serenoa repens) is a small palm tree native to the southeastern United States — particularly Florida, Georgia, and the Gulf Coast. It produces dark purple berries that Indigenous populations consumed for urinary and reproductive health for centuries before European colonization. Modern extraction methods target the lipidosterolic fraction of the berries, which contains the fatty acids and phytosterols believed to drive Saw Palmetto's biological effects.
The main active compounds in standardized Saw Palmetto extract are free fatty acids (particularly lauric, oleic, myristic, and palmitic acid), phytosterols (beta-sitosterol being the most abundant), and long-chain alcohols. Standardized extracts are calibrated to contain 85–95% fatty acids to ensure consistent potency across batches and products.
Saw Palmetto's primary documented mechanism is inhibition of 5-alpha reductase (5AR). This enzyme converts testosterone into dihydrotestosterone (DHT) — a hormone significantly more potent than testosterone in prostate tissue. Elevated DHT over decades drives prostate cell proliferation, which is one of the key biological drivers of age-related prostate enlargement.
By slowing the conversion of testosterone into DHT within prostate tissue, Saw Palmetto helps reduce one of the root causes of BPH — not just the symptoms. This is why Saw Palmetto's effects build slowly (weeks to months of consistent use) rather than producing immediate improvement. Unlike alpha-blocker drugs (like Flomax) that relax smooth muscle for fast symptom relief without addressing root causes, Saw Palmetto works upstream on the actual biological driver.
Secondary mechanisms that have been investigated include anti-inflammatory effects on prostate tissue, inhibition of growth factor signaling involved in prostate cell proliferation, and mild alpha-adrenergic blocking activity (similar to but much weaker than pharmaceutical alpha-blockers).
Saw Palmetto is one of the most extensively studied herbal supplements. The Cochrane Collaboration — an internationally respected independent research organization that reviews medical evidence — has conducted multiple meta-analyses of Saw Palmetto for BPH. A 2009 Cochrane review examined 30 randomized controlled trials and found Saw Palmetto produced modest but measurable improvements in urinary symptoms and flow measures compared to placebo (PMID 19370658).
Additional trials have examined Saw Palmetto head-to-head against the pharmaceutical 5-alpha reductase inhibitor finasteride. Some studies have shown comparable effectiveness with a substantially better side-effect profile for Saw Palmetto — no reports of sexual dysfunction that commonly affect finasteride users. Other studies have shown finasteride slightly more effective on certain measures. Overall, the research picture supports Saw Palmetto as a reasonable first-line approach for men with mild to moderate BPH symptoms who prefer to avoid pharmaceutical side effects.
Most men report noticeable improvement in urinary symptoms within 4 to 12 weeks of consistent daily supplementation. This timeline reflects the underlying biology: DHT reduction and subsequent tissue changes happen gradually, not instantly. Clinical trials typically run 3 to 6 months to allow full effects to develop.
The most commonly reported first change: nighttime urination frequency. Men going 3 to 4 times a night often report reduction to 1–2 times by weeks 3–6. Urine stream strength typically follows over weeks 5–12. Full effects develop by month 3 to 6. This is why the 6-bottle (180-day supply) package is the recommended choice for men seriously trialing Saw Palmetto-containing formulas.
Clinical trials have used Saw Palmetto extracts standardized to 85–95% fatty acids, typically at 320 mg per day (often split as 160 mg twice daily). Products using powdered whole berry rather than standardized extract deliver much lower doses of active compounds and should not be assumed equivalent.
In ViriFlow, Saw Palmetto is delivered in liquid drop form alongside eight other active ingredients. The liquid format allows consistent daily dosing without the variability that can affect capsule absorption, and positions Saw Palmetto within a multi-pathway formula rather than as a standalone approach.
Saw Palmetto is generally well-tolerated. The most commonly reported side effects in clinical trials are mild gastrointestinal symptoms (nausea, stomach upset) in a small percentage of users. These typically resolve with food or within a few days of adjustment.
The most important safety consideration is interaction with blood-thinning medications (warfarin, apixaban, rivaroxaban, aspirin at high doses). Saw Palmetto has mild anticoagulant effects and may increase bleeding risk when combined with these drugs. Men on anticoagulants should consult their physician before starting any Saw Palmetto-containing supplement.
Saw Palmetto may also theoretically interact with hormonal therapies (testosterone replacement, anti-androgens, oral contraceptives — though contraceptives aren't relevant to male users). Any man on hormonal therapy should discuss supplementation with their prescribing physician.
Saw Palmetto is best suited for men 40+ with mild to moderate lower urinary tract symptoms — the classic pattern of weaker stream, increased nighttime urination, sensation of incomplete emptying, and urgency that emerges gradually with age. It is not an appropriate primary treatment for severe BPH with urinary retention, suspected or diagnosed prostate cancer, or acute urinary tract infection — all of which require physician evaluation.
Men currently taking prescription medications for BPH should not stop those medications to try Saw Palmetto without physician supervision. Saw Palmetto can often complement ongoing treatment but should be coordinated with the prescribing doctor.
In ViriFlow, Saw Palmetto anchors the prostate-support side of the formula alongside Pygeum Africanum (which targets nocturia and bladder emptying specifically) and Neem (urinary tract cleansing). The Saw Palmetto + Pygeum combination is well-documented in clinical literature as complementary — they target different aspects of the prostate/urinary problem and work through different mechanisms.
Adding the marine ingredients (Wakame, Kelp, Nori Yaki, Bladderwrack) brings mineral-flushing support that helps address hard-water mineral deposits that amplify the effects of age-related prostate enlargement. Shilajit and Pomegranate round out the formula with testosterone/vitality support and antioxidant protection.
If you're a man over 40 with early prostate or urinary symptoms, Saw Palmetto is one of the most reasonable starting points — substantial research support, good safety profile, and relatively inexpensive access. In a multi-pathway formula like ViriFlow, it does more than it can do alone because the other ingredients address dimensions of the problem Saw Palmetto doesn't target.
Give any Saw Palmetto-containing supplement 60 to 90 days of consistent daily use before evaluating whether it's working for you. Single-bottle trials (30 days) are usually too short to see the full effect. If symptoms are severe or rapidly worsening, see a urologist — supplements are not appropriate substitutes for medical evaluation of significant symptoms.
